Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice

Human Gene Therapy

Volumn 9, Issue 12, 1998, Pages 1701-1707

  Nitta, Yoshio ^a,b   Tashiro, Fumi ^a   Tokui, Mikiya ^c   Shimada, Akira ^c   Takei, Izumi ^c   Tabayashi, Koichi ^b   Miyazaki, Jun Ichi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PLASMID DNA;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PROPHYLAXIS;

EID: 0032504602     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.12-1701     Document Type: Article

References (10)

1. ADORINI, L., and TREMBLEAU, S. (1997). Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes. Biochem. Soc. Trans. 25, 625-629.
2. BEDOSSA, P., BENDELAC, A., BACH, J.F., and CARNAUD, C. (1989). Syngeneic T cell transfer of diabetes into NOD newborn mice: In situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur. J. Immunol. 19, 1947-1951.
3. + T cells. J. Exp. Med. 166, 823-832.
4. BUER, J., LANOUE, A., FRANZKE, A., GARCIA, C., VON BOEHMER, H., and SARUKHAN, A. (1998). Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187, 177-183.
5. CANNELLA, B., GAO, Y.L., BROSNAN, C., and RAINE, C.S. (1996). IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45, 735-746.
6. CASTANO, L., and EISENBARTH, G.S. (1990). Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8, 647-679.
7. CHERNOFF, A.E., GRANOWITZ, E.V., SHAPIRO, L., VANNIER, E., LONNEMANN, G., ANGEL, J.B., KENNEDY, J.S., RABSON, A.R., WOLFF, S.M., and DINARELLO, C.A. (1995). A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154, 5492-5499.
8. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (London) 389, 737-742.
9. ITAKURA, M., MORITANI, M., YOSHIMOTO, K., HASHIMOTO, C., OTSUKA, S., SANO, T., and MIYAZAKI, J. (1996). Immunostimulatory versus immunosuppressive roles of IL-10 in IDDM: Analysis with IL-10-producing transgenic NOD mice. In Lessons from Animal Diabetes VI. E. Shafrir, ed. (Birkhauser, Boston), pp. 149-173.
10. YANG, X.-D., TISCH, R., SINGER, S.M., CAO, Z.A., LIBLAU, R.S., SCHREIBER, R.D., and MCDEVITT, H.O. (1994). Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180, 995-1004.